Cryo-Cell Net Profit Margin 2010-2024 | CCEL
Cryo-Cell net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Cryo-Cell Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-08-31 | $0.03B | $-0.01B | -25.00% |
| 2024-05-31 | $0.03B | $-0.01B | -25.00% |
| 2024-02-29 | $0.03B | $-0.01B | -28.13% |
| 2023-11-30 | $0.03B | $-0.01B | -28.13% |
| 2023-08-31 | $0.03B | $0.00B | 9.38% |
| 2023-05-31 | $0.03B | $0.00B | 6.25% |
| 2023-02-28 | $0.03B | $0.00B | 9.38% |
| 2022-11-30 | $0.03B | $0.00B | 9.68% |
| 2022-08-31 | $0.03B | $0.00B | 3.33% |
| 2022-05-31 | $0.03B | $0.00B | 6.67% |
| 2022-02-28 | $0.03B | $0.00B | 6.90% |
| 2021-11-30 | $0.03B | $0.00B | 6.90% |
| 2021-08-31 | $0.03B | $0.00B | 13.33% |
| 2021-05-31 | $0.03B | $0.00B | 13.33% |
| 2021-02-28 | $0.03B | $0.00B | 12.90% |
| 2020-11-30 | $0.03B | $0.00B | 12.50% |
| 2020-08-31 | $0.03B | $0.00B | 12.50% |
| 2020-05-31 | $0.03B | $0.00B | 12.50% |
| 2020-02-29 | $0.03B | $0.00B | 9.38% |
| 2019-11-30 | $0.03B | $0.00B | 6.45% |
| 2019-08-31 | $0.03B | $0.00B | 6.25% |
| 2019-05-31 | $0.03B | $0.00B | 3.13% |
| 2019-02-28 | $0.03B | $0.00B | 6.45% |
| 2018-11-30 | $0.03B | $-0.00B | -3.33% |
| 2018-08-31 | $0.03B | $-0.00B | -3.70% |
| 2018-05-31 | $0.03B | 0 | 0.00% |
| 2018-02-28 | $0.03B | $-0.00B | -4.00% |
| 2017-11-30 | $0.03B | $0.00B | 8.00% |
| 2017-08-31 | $0.03B | $0.00B | 8.00% |
| 2017-05-31 | $0.02B | $-0.00B | -8.33% |
| 2017-02-28 | $0.02B | $-0.00B | -4.17% |
| 2016-11-30 | $0.02B | $-0.00B | -4.35% |
| 2016-08-31 | $0.02B | $-0.00B | -8.70% |
| 2016-05-31 | $0.02B | $0.01B | 40.91% |
| 2016-02-29 | $0.02B | $0.01B | 38.10% |
| 2015-11-30 | $0.02B | $0.01B | 38.10% |
| 2015-08-31 | $0.02B | $0.01B | 40.00% |
| 2015-05-31 | $0.02B | 0 | 0.00% |
| 2015-02-28 | $0.02B | 0 | 0.00% |
| 2014-11-30 | $0.02B | 0 | 0.00% |
| 2014-08-31 | $0.02B | 0 | 0.00% |
| 2014-05-31 | $0.02B | 0 | 0.00% |
| 2014-02-28 | $0.02B | 0 | 0.00% |
| 2013-11-30 | $0.02B | 0 | 0.00% |
| 2013-08-31 | $0.02B | $-0.00B | -5.00% |
| 2013-05-31 | $0.02B | $-0.00B | -10.00% |
| 2013-02-28 | $0.02B | $-0.01B | -26.32% |
| 2012-11-30 | $0.02B | $-0.01B | -38.89% |
| 2012-08-31 | $0.02B | $-0.01B | -35.29% |
| 2012-05-31 | $0.02B | $-0.01B | -43.75% |
| 2012-02-29 | $0.02B | $-0.00B | -23.53% |
| 2011-11-30 | $0.02B | $-0.00B | -11.76% |
| 2011-08-31 | $0.02B | $-0.00B | -11.11% |
| 2011-05-31 | $0.02B | $0.00B | 10.53% |
| 2011-02-28 | $0.02B | $0.00B | 11.11% |
| 2010-11-30 | $0.02B | $0.00B | 11.11% |
| 2010-08-31 | $0.02B | $0.00B | 11.76% |
| 2010-05-31 | $0.02B | 0 | 0.00% |
| 2010-02-28 | $0.02B | $0.00B | 5.56% |
| 2009-11-30 | $0.02B | $0.00B | 11.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.075B | $0.031B |
| CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $95.766B | 11.88 |
| Cencora (COR) | United States | $49.023B | 18.08 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| ICON (ICLR) | Ireland | $17.511B | 15.60 |
| Natera (NTRA) | United States | $16.712B | 0.00 |
| Viatris (VTRS) | United States | $15.433B | 4.75 |
| Avantor (AVTR) | United States | $14.831B | 22.24 |
| Revvity (RVTY) | United States | $14.647B | 25.44 |
| BioMerieux (BMXMF) | France | $12.894B | 0.00 |
| CochLear (CHEOY) | Australia | $12.739B | 0.00 |
| Solventum (SOLV) | United States | $12.214B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.215B | 31.59 |
| Charles River Laboratories (CRL) | United States | $11.042B | 21.34 |
| Doximity (DOCS) | United States | $10.778B | 63.79 |
| HealthEquity (HQY) | United States | $8.750B | 47.49 |
| Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.881B | 32.03 |
| Life Times (LTH) | United States | $5.005B | 33.12 |
| Sotera Health (SHC) | United States | $4.402B | 23.55 |
| Organon (OGN) | United States | $4.012B | 4.05 |
| Surgery Partners (SGRY) | United States | $3.759B | 42.85 |
| BrightSpring Health Services (BTSG) | United States | $3.402B | 72.37 |
| PACS (PACS) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.579B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.523B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.446B | 0.00 |
| Premier (PINC) | United States | $2.301B | 11.48 |
| GeneDx Holdings (WGS) | United States | $2.113B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.783B | 47.00 |
| Teladoc Health (TDOC) | United States | $1.670B | 0.00 |
| Progyny (PGNY) | United States | $1.551B | 29.62 |
| Pediatrix Medical (MD) | United States | $1.331B | 13.02 |
| CareDx (CDNA) | United States | $1.251B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Embecta (EMBC) | United States | $0.898B | 5.99 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| InnovAge Holding (INNV) | United States | $0.778B | 0.00 |
| Agilon Health (AGL) | United States | $0.770B | 0.00 |
| SBC Medicals (SBC) | United States | $0.717B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.442B | 0.00 |
| DocGo (DCGO) | United States | $0.426B | 16.00 |
| Enhabit (EHAB) | United States | $0.383B | 33.09 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.346B | 0.00 |
| LifeMD (LFMD) | United States | $0.310B | 0.00 |
| ModivCare (MODV) | United States | $0.244B | 13.24 |
| Sera Prognostics (SERA) | United States | $0.242B | 0.00 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Nutex Health (NUTX) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.204B | 0.00 |
| MultiPlan (MPLN) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.120B | 0.00 |
| So-Young (SY) | China | $0.073B | 17.77 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.12 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |